Medicine and Dentistry
Adenoid Hypertrophy
11%
Ankle Brachial Index
11%
Anomalous Pulmonary Venous Connection
11%
Apnea
18%
Asthma
11%
Atrial Septal Defect
14%
Bleeding
11%
Bronchodilating Agent
11%
Case Presentation
15%
Central Sleep Apnea
11%
Cervical Spine Radiography
11%
Chronic Obstructive Pulmonary Disease
11%
Clinician
11%
Cohort Analysis
11%
Disease
27%
Down Syndrome
18%
Drug Resistant Epilepsy
11%
Dyspnea
28%
Echocardiography
17%
Enteric Feeding
23%
Epileptic Seizure
12%
Exercise
25%
G Protein Coupled Receptor
11%
Gasping
17%
Gastrointestinal Bleeding
15%
Heart Amyloidosis
11%
Hemodynamic
19%
Human Immunodeficiency Virus
11%
Hypopnea
18%
Idiopathic Pulmonary Fibrosis
24%
Infectious Complication
11%
Intensive Care Unit
19%
Interstitial Lung Disease
12%
Intractable Epilepsy
11%
Ischemic Mitral Valve Regurgitation
11%
Mediastinitis
11%
Mental Health
13%
Obstructive Sleep Apnea
25%
Post-Hoc Analysis
11%
Pulmonary Artery
22%
Pulmonary Hypertension
100%
Quality Improvement
11%
Rosai-Dorfman Disease
11%
Stress Ulcer
23%
Stroke Volume
23%
Tertiary Care
23%
Therapy Delay
11%
Treprostinil
14%
Vasodilator Agent
18%
Virus Infection
11%
Keyphrases
Acute Ischemic Mitral Regurgitation
11%
Adenoid Hypertrophy
11%
Antimony
11%
Associated Diseases
11%
Bleeding
11%
Bridge-to-surgery
11%
Cardiovascular Disease
8%
Cardiovascular Effects
11%
Carotid Flow Time
11%
Case-cohort Study
11%
Closed Model
11%
Cryptococcus
11%
Defect Management
11%
Enteral nutrition
11%
Environmental Metals
23%
Event Distribution
11%
Extraintestinal Manifestations
11%
Fibroblast Heterogeneity
11%
Fibroblasts
11%
Fibrosing Mediastinitis
11%
Fraction Volume
11%
G Protein-coupled Receptor
11%
Hoarseness of Voice
11%
Inhalable Dry Powder
11%
Inhaled Treprostinil
20%
International Case
11%
Interstitial Lung Disease
11%
Krukenberg Tumor
11%
Massive Pulmonary Embolism
11%
Molar Tooth Sign
11%
MR-proADM
11%
Necrobiotic
11%
Oropharyngeal
11%
Peritonitis
11%
Proton Pump Inhibitors
11%
Pseudoaneurysm
11%
Pulmonary Artery
11%
Pulmonary Hypertension
17%
Pulmonary Hypertension Treatment
11%
Real-world Treatment Patterns
11%
Redox Homeostasis
11%
Resident Continuity Clinic
11%
Smoking-related Interstitial Fibrosis
11%
Treatment Delay
11%
Typical Carcinoid
11%
Tyvaso
11%
Upper Gastrointestinal Tract
11%
Vasodilator
11%
Vici Syndrome
11%
Wood
9%
Pharmacology, Toxicology and Pharmaceutical Science
Apnea
19%
Atherosclerosis
8%
Cardiovascular Disease
11%
Case-Control Study
11%
Clinical Study
21%
Clinical Trial
10%
Combination Therapy
6%
Coronary Artery Disease
5%
Disease
23%
Disease Exacerbation
8%
Down Syndrome
11%
Epileptic Absence
5%
G Protein Coupled Receptor
11%
Gastrointestinal Hemorrhage
20%
Heart Atrium Septum Defect
11%
Heart Failure
11%
Heart Infarction
5%
Heart Ventricle Remodeling
5%
Heavy Metal
8%
HIV
11%
Human Immunodeficiency Virus Infection
8%
Hypertension
11%
Inflammation
11%
Interstitial Lung Disease
12%
Ion Channel
5%
Lung Disease
7%
Lung Embolism
11%
Mediastinitis
11%
Obstruction
5%
Pantoprazole
5%
Pathophysiology
5%
Peripheral Occlusive Artery Disease
11%
Placebo
11%
Prevalence
8%
Proadrenomedullin
11%
Proton Pump Inhibitor
11%
Pulmonary Hypertension
88%
Rectum Carcinoma
5%
Retrospective Study
8%
Sleep Disordered Breathing
23%
Stress Ulcer
23%
Syndrome
5%
Thorax Pain
5%
Tolerability
11%
Treprostinil
35%
Vascular Remodeling
5%
